Affiliation:
1. Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
3. Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
4. CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain
Abstract
ABSTRACT
There is no precise information available on the entire workload of isolating a specific microorganism in a clinical microbiology laboratory, and the costs associated with it have not been specifically estimated. In this descriptive retrospective study conducted at the microbiology department of a general teaching hospital from January 2021 to December 2022, we assessed the workload associated with identifying
Candida
species in all types of clinical samples and patients. Costs were estimated from data obtained from the hospital’s finance department and microbiology laboratory cost records. In 2 years, 1,008,231 samples were processed at our microbiology department, of which 8,775 had one or more
Candida
spp. isolates (9,683 total isolates). Overall, 5,151 samples with
Candida
spp. were identified from 2,383 inpatients. We isolated
Candida
spp. from 515.3 samples/100,000 population/year and from 92 samples/1,000 hospital admissions/year. By sample type, 90.8% were superficial, mainly mucosal. Only 9.1%
Candida
spp. were isolated from deep, usually sterile, samples, being mostly from ordinarily sterile fluids.
Candida albicans
was the main species (58.5%) identified, followed by
C. parapsilosis
complex,
C. glabrata
,
C. tropicalis,
and
C. krusei
. In admitted patients, the incidences of samples with
Candida
spp. isolates were 302.7 samples/100,000 population/year and 54 samples/1,000 admissions/year. The average cost of isolating and identifying
Candida
spp. was estimated at 25€ per culture-positive sample. To our knowledge, this is the first attempt to gage the workload and costs of
Candida
spp. isolation at a hospital microbiology department. These data can help assess the burden and significance of
Candida
isolation at other institutions and also help design measures for streamlining.
IMPORTANCE
We believe that this work is of interest because at present, there is no really accurate information available on the total workload involved in isolating a specific microorganism in a clinical microbiology laboratory. The costs related to this have also not been described. We have described the unrestricted workload of Candida spp. in all types of samples for all types of species and patients. We believe that this information would be necessary to collect and share this information as well as to collect it in a standardized way to know the current situation of Candida spp. workload in all clinical microbiology laboratories.
Funder
MEC | Instituto de Salud Carlos III
Publisher
American Society for Microbiology